New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease

New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease

Aim. To evaluate the relationship between albumin to creatinine ratio (ACR) in a single and 24-hours urine spots and chronic kidney disease (CKD) progression pace in patients with atrial fibrillation, CKD and diabetes mellitus.Material and methods. 60 patients with atrial fibrillation (AF) and CKD w...

Full description

Bibliographic Details
Main Authors:	A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2021-07-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	albumin to creatinine ratio chronic kidney disease atrial fibrillation diabetes mellitus albuminuria
Online Access:	https://www.rpcardio.online/jour/article/view/2499

Similar Items

Associations Between Albuminuria and Mortality Among US Adults by Demographic and Comorbidity Factors
by: Yelena Drexler, et al.
Published: (2023-11-01)

Health Risk in a Geographic Area of Thailand with Endemic Cadmium Contamination: Focus on Albuminuria
by: Soisungwan Satarug, et al.
Published: (2023-01-01)

Positive correlation between hypertensive retinopathy and albuminuria in hypertensive adults
by: Jun Li, et al.
Published: (2023-02-01)

Evaluation of Urinary Indices for Albuminuria and Proteinuria in Patients with Chronic Kidney Disease
by: Dennis Sung Chul Hong, et al.
Published: (2016-04-01)

Increasing obstructive sleep apnea risk is associated with albuminuria in Korean adults: cross-sectional analysis
by: Suk Won Chang, et al.
Published: (2024-03-01)

Association of high‐normal albuminuria and vascular aging: Hanzhong adolescent hypertension study
by: Ming‐Fei Du, et al.
Published: (2023-12-01)

Animal Fat Intake Is Associated with Albuminuria in Patients with Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome
by: Manuela Abbate, et al.
Published: (2021-05-01)

Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022-11-01)

Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy
by: D. A. Napalkov, et al.
Published: (2019-09-01)

Prevalence and Spectrum of Albuminuria among Type 2 Diabetic Patients in a Tertiary Health-care Facility in Southern Nigeria
by: Beniboba Jenewari Eleki, et al.
Published: (2023-01-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

Safety of dabigatran in patients with atrial fibrillation and chronic kidney disease: pharmacokinetic and pharmacogenetic aspects
by: A. I. Skripka, et al.
Published: (2020-01-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

Risk factors for late recurrence in patients with nonvalvular atrial fibrillation after radiofrequency catheter ablation
by: Zhang Peng, et al.
Published: (2022-03-01)

Laboratory predictors of clinical outcomes in patients with atrial fibrillation
by: A. A. Sokolova, et al.
Published: (2021-05-01)

Atrial Fibrillation Associated with Anticancer Drugs
by: O. D. Ostroumova, et al.
Published: (2020-12-01)

The Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China
by: Hong Lian, et al.
Published: (2021-05-01)

Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study
by: Shilan Seyed Ahmadi, et al.
Published: (2020-01-01)

Elderly patient with atrial fibrillation and comorbid pathology: therapeutic potential of dabigatrane administration
by: D. A. Napalkov, et al.
Published: (2018-04-01)

Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable
by: D. A. Napalkov, et al.
Published: (2018-11-01)

Ischaemia-modified Albumin Estimation and Usefulness of Different Albumin Adjustment as a Marker to Predict Kidney Damage in Diabetes Mellitus
by: Afzal Ahmad, et al.
Published: (2023-09-01)

Why 24-h urine albumin excretion rate method still is used for screening of diabetic nephropathy in Isfahan laboratories?
by: Azam Teimoury, et al.
Published: (2014-01-01)

SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: A TWO-YEAR COHORT STUDY
by: A. V. Zhilenko, et al.
Published: (2017-07-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

A POSSIBILITY TO USE ANTIARRHYTHMIC MEDICATIONS FROM II CLASS AND MODULATED KINESITHERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN METABOLIC SYNDROME PATIENTS
by: A. I. Olesin, et al.
Published: (2015-11-01)

Current Predictors of Atrial Fibrillation Progression
by: V. I. Podzolkov, et al.
Published: (2019-05-01)

The pathogenesis of albuminuria in cadmium nephropathy
by: Soisungwan Satarug, et al.
Published: (2024-01-01)

Association between the Albumin-to-Globulin Ratio and Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
by: Zhongyu Yuan, et al.
Published: (2024-03-01)

Serum Cystatin C Reflects the Progress of Albuminuria
by: Jeong Seon Yoo, et al.
Published: (2011-12-01)

Telocytes and Atrial Fibrillation: From Basic Research to Clinical Practice
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016-11-01)

Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Yapeng Wang, et al.
Published: (2023-01-01)

ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY
by: A. I. Olesin, et al.
Published: (2014-12-01)

Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)

Risk of Venous Thromboembolic Complications in Patients with Atrial Fibrillation: a Systematic Review and Meta-analysis
by: A. A. Sokolova, et al.
Published: (2022-07-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
by: A. А. Sokolova, et al.
Published: (2017-12-01)

Relationship between creatinine clearance and clinical outcomes in Chinese emergency patients with atrial fibrillation
by: Juan Wang, et al.
Published: (2022-05-01)

Albumin as a Prognostic Marker for Atrial Fibrillation Recurrence following Cryoballoon Ablation of Pulmonary Venous
by: Nili Schamroth Pravda, et al.
Published: (2022-12-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)